MEDILINK - Biocon (Diabetic) (25)

We are instrumental in trading a qualitative range of Biocon Diabetic including Pharmaceutical Formulations - Ranibizumab 30 mg/ml Injection, Pre-filled Syringe | Targeted Therapy, High Potency, Biosimilar Option, 24 Months Shelf Life, Pharmaceutical Formulations - White, 100 Units Injection | Diabetes Control, Blood Sugar, Fast Acting, Long Acting, Patient Safety, Refrigerated Carton Packaging, Pharmaceutical Formulations - 200 mg Tablets, Blister Pack | Targeted Therapy, Cancer Treatment, Dosage Control, Oral Administration, Improved Efficacy etc.